Kalif Eliyahu Sharon
EVP, Chief Financial Officer · 8 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-11 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Sale | 106,563 | $34.10 | $3.6M | filing |
| 2026-05-14 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Sale | 153,251 | $35.61 | $5.5M | filing |
| 2026-03-05 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Option exercise | 19,916 | — | — | filing |
| 2026-03-04 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Option exercise | 33,512 | — | — | filing |
| 2026-03-04 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Option exercise | 23,251 | — | — | filing |
| 2026-03-03 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Option exercise | 49,800 | — | — | filing |
| 2026-03-03 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Option exercise | 141,478 | — | — | filing |
| 2026-02-26 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Sale | 345,810 | $33.64 | $11.6M | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.